ASCENDIS PHARMA A/S Financials, key figures and credit report
Net sales 105.4 mEUR FY 2022
EBIT margin - 168.9 % FY 2022
Net debt — FY 2022
Quick ratio — FY 2022
Income statement (mEUR)
2018 | 2019 | 2022 | |
|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 |
| Net sales | 25.29 | 40.45 | 105.37 |
| Costs of manufacturing | -13.86 | ||
| Gross profit | 25.29 | 40.45 | 91.51 |
| Costs of management | -21.67 | ||
| Costs of marketing | - 134.17 | ||
| Other operating expenses | -47.43 | - 122.15 | - 135.29 |
| EBIT | -43.81 | -81.71 | - 177.95 |
| Other financial income | 31.03 | 28.07 | 82.24 |
| Other financial expenses | -0.38 | -0.84 | -47.37 |
| Pre-tax profit | -13.16 | -54.48 | - 143.08 |
| Income taxes | 0.74 | -0.95 | 0.18 |
| Net earnings | -12.42 | -55.43 | - 142.90 |
Assets (mEUR)
2018 | 2019 | |
|---|---|---|
| Intangible assets total | ||
| Other tangible assets | 0.98 | 11.75 |
| Tangible assets total | 0.98 | 11.75 |
| Holdings in group member companies | 23.47 | 48.60 |
| Investments total | 23.47 | 48.60 |
| Non-curr. owed by group member comp. | 348.67 | 497.16 |
| Non-current other receivables | 0.94 | 0.95 |
| Long term receivables total | 349.61 | 498.11 |
| Inventories total | ||
| Prepayments and accrued income | 0.67 | 1.05 |
| Current other receivables | 0.97 | 3.18 |
| Current deferred tax assets | 0.74 | |
| Short term receivables total | 2.38 | 4.23 |
| Cash and bank deposits | 251.78 | 567.11 |
| Cash and cash equivalents | 251.78 | 567.11 |
| Balance sheet total (assets) | 628.21 | 1 129.80 |
Equity and liabilities (mEUR)
2018 | 2019 | 2022 | |
|---|---|---|---|
| Share capital | 5.66 | 6.44 | |
| Other reserves | 580.49 | 1 059.39 | |
| Retained earnings | 12.42 | 55.43 | 142.90 |
| Profit of the financial year | -12.42 | -55.43 | - 142.90 |
| Shareholders equity total | 586.15 | 1 065.83 | |
| Non-current loans from credit institutions | 8.71 | ||
| Non-current other liabilities | 0.91 | ||
| Non-current liabilities total | 9.62 | ||
| Current leasing loans | 2.05 | ||
| Current trade creditors | 9.67 | ||
| Current owed to group member | 17.50 | 15.53 | |
| Other non-interest bearing current liabilities | 14.65 | 28.76 | |
| Accruals and deferred income | 0.25 | 8.01 | |
| Current liabilities total | 42.06 | 54.35 | |
| Balance sheet total (liabilities) | 628.21 | 1 129.80 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated